MIRA Pharmaceuticals Reports MIRA-55 Pain Relief in Study

The company reports that its proof-of-concept study found sustained efficacy without observed tolerance, reduced inflammation-associated swelling and favorable tolerability. The headline says pain relief was comparable to Celebrex.